Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003823
Filing Date
2025-03-27
Accepted
2025-03-27 16:21:53
Documents
126
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ganx-20241231x10k.htm   iXBRL 10-K 2588133
2 EX-4.1 ganx-20241231xex4d1.htm EX-4.1 47227
3 EX-10.18 ganx-20241231xex10d18.htm EX-10.18 41589
4 EX-19.1 ganx-20241231xex19d1.htm EX-19.1 113606
5 EX-21.1 ganx-20241231xex21d1.htm EX-21.1 3530
6 EX-23.1 ganx-20241231xex23d1.htm EX-23.1 6189
7 EX-31.1 ganx-20241231xex31d1.htm EX-31.1 10672
8 EX-31.2 ganx-20241231xex31d2.htm EX-31.2 10636
9 EX-32.1 ganx-20241231xex32d1.htm EX-32.1 10408
10 GRAPHIC ganx-20241231x10k001.jpg GRAPHIC 36401
11 GRAPHIC ganx-20241231x10k002.jpg GRAPHIC 47908
12 GRAPHIC ganx-20241231x10k003.jpg GRAPHIC 69003
13 GRAPHIC ganx-20241231x10k004.jpg GRAPHIC 32775
14 GRAPHIC ganx-20241231x10k005.jpg GRAPHIC 41795
15 GRAPHIC ganx-20241231xex10d18001.jpg GRAPHIC 3356
16 GRAPHIC ganx-20241231xex10d18002.jpg GRAPHIC 3325
  Complete submission text file 0001558370-25-003823.txt   12630496

Data Files

Seq Description Document Type Size
17 EX-101.SCH ganx-20241231.xsd EX-101.SCH 78816
18 EX-101.CAL ganx-20241231_cal.xml EX-101.CAL 78866
19 EX-101.DEF ganx-20241231_def.xml EX-101.DEF 278422
20 EX-101.LAB ganx-20241231_lab.xml EX-101.LAB 704670
21 EX-101.PRE ganx-20241231_pre.xml EX-101.PRE 541351
129 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20241231x10k_htm.xml XML 2152956
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40237 | Film No.: 25779608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)